• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Multimodal Loading Environment Predicts Bioresorbable Vascular Scaffolds' Durability.多模态加载环境预测生物可吸收血管支架的耐久性。
Ann Biomed Eng. 2021 May;49(5):1298-1307. doi: 10.1007/s10439-020-02673-z. Epub 2020 Oct 29.
2
Effect of working environment and procedural strategies on mechanical performance of bioresorbable vascular scaffolds.工作环境和程序策略对生物可吸收血管支架机械性能的影响。
Acta Biomater. 2018 Dec;82:34-43. doi: 10.1016/j.actbio.2018.10.020. Epub 2018 Oct 17.
3
Comparative Study of Degradation Behavior of Bioresorbable Cardiovascular Scaffolds.生物可吸收心血管支架降解行为的比较研究
Cardiovasc Eng Technol. 2015 Mar;6(1):71-9. doi: 10.1007/s13239-014-0199-1. Epub 2014 Nov 11.
4
A model of polymer degradation and erosion for finite element analysis of bioresorbable implants.可吸收植入物有限元分析的聚合物降解和侵蚀模型。
J Mech Behav Biomed Mater. 2020 Dec;112:104022. doi: 10.1016/j.jmbbm.2020.104022. Epub 2020 Aug 6.
5
Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.依维莫司洗脱生物可吸收血管支架与依维莫司洗脱金属支架的比较:随机对照试验的荟萃分析。
Lancet. 2016 Feb 6;387(10018):537-544. doi: 10.1016/S0140-6736(15)00979-4. Epub 2015 Nov 17.
6
Effect of two-year degradation on mechanical interaction between a bioresorbable scaffold and blood vessel.两年降解对生物可吸收支架与血管间力学相互作用的影响。
J Mech Behav Biomed Mater. 2018 Feb;78:254-265. doi: 10.1016/j.jmbbm.2017.11.031. Epub 2017 Nov 21.
7
Comparative Characterization of Biomechanical Behavior and Healing Profile of a Novel Ultra-High-Molecular-Weight Amorphous Poly-l-Lactic Acid Sirolimus-Eluting Bioresorbable Coronary Scaffold.新型超高分子量无定形聚左旋乳酸西罗莫司洗脱生物可吸收冠状动脉支架的生物力学行为和愈合情况的比较特征
Circ Cardiovasc Interv. 2016 Oct;9(10). doi: 10.1161/CIRCINTERVENTIONS.116.004253.
8
Strut protrusion and shape impact on endothelial shear stress: insights from pre-clinical study comparing Mirage and Absorb bioresorbable scaffolds.支柱突出及形状对内皮剪切应力的影响:比较Mirage和Absorb生物可吸收支架的临床前研究见解
Int J Cardiovasc Imaging. 2017 Sep;33(9):1313-1322. doi: 10.1007/s10554-017-1124-0. Epub 2017 Apr 1.
9
Randomized Comparison of Absorb Bioresorbable Vascular Scaffold and Mirage Microfiber Sirolimus-Eluting Scaffold Using Multimodality Imaging.随机比较 Absorb 生物可吸收血管支架和 Mirage 微纤维西罗莫司洗脱支架的多模式影像学研究。
JACC Cardiovasc Interv. 2017 Jun 12;10(11):1115-1130. doi: 10.1016/j.jcin.2017.03.015. Epub 2017 May 17.
10
A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.一种新一代生物可吸收冠状动脉支架系统:从实验室到首次临床评估:6 个月和 12 个月的临床和多模态影像学结果。
JACC Cardiovasc Interv. 2014 Jan;7(1):89-99. doi: 10.1016/j.jcin.2013.07.007. Epub 2013 Oct 16.

引用本文的文献

1
From the real device to the digital twin: A coupled experimental-numerical strategy to investigate a novel bioresorbable vascular scaffold.从真实设备到数字孪生:一种用于研究新型生物可吸收血管支架的耦合并行实验-数值策略。
PLoS One. 2021 Jun 4;16(6):e0252788. doi: 10.1371/journal.pone.0252788. eCollection 2021.

本文引用的文献

1
In vitro mechanical behavior and in vivo healing response of a novel thin-strut ultrahigh molecular weight poly-l-lactic acid sirolimus-eluting bioresorbable coronary scaffold in normal swine.新型超薄高强聚左旋乳酸西罗莫司洗脱可吸收冠状动脉支架在正常猪体内的体外力学性能和体内愈合反应。
Int J Cardiol. 2019 Jul 1;286:21-28. doi: 10.1016/j.ijcard.2019.04.012. Epub 2019 Apr 4.
2
Effect of working environment and procedural strategies on mechanical performance of bioresorbable vascular scaffolds.工作环境和程序策略对生物可吸收血管支架机械性能的影响。
Acta Biomater. 2018 Dec;82:34-43. doi: 10.1016/j.actbio.2018.10.020. Epub 2018 Oct 17.
3
Strain-induced accelerated asymmetric spatial degradation of polymeric vascular scaffolds.应变诱导的聚合物血管支架的加速不对称空间降解。
Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2640-2645. doi: 10.1073/pnas.1716420115. Epub 2018 Feb 26.
4
Effect of two-year degradation on mechanical interaction between a bioresorbable scaffold and blood vessel.两年降解对生物可吸收支架与血管间力学相互作用的影响。
J Mech Behav Biomed Mater. 2018 Feb;78:254-265. doi: 10.1016/j.jmbbm.2017.11.031. Epub 2017 Nov 21.
5
Three-Year Outcomes With the Absorb Bioresorbable Scaffold: Individual-Patient-Data Meta-Analysis From the ABSORB Randomized Trials.Absorb 生物可吸收支架的 3 年结果:来自 ABSORB 随机试验的个体患者数据汇总分析。
Circulation. 2018 Jan 30;137(5):464-479. doi: 10.1161/CIRCULATIONAHA.117.031843. Epub 2017 Oct 31.
6
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary.ESC-EAPCI 工作组关于经皮冠状动脉介入治疗中生物可吸收支架评估和应用的报告:执行摘要。
EuroIntervention. 2018 Jan 20;13(13):1574-1586. doi: 10.4244/EIJ20170912-01.
7
Mechanical behavior of polymer-based . metallic-based bioresorbable stents.基于聚合物和金属的生物可吸收支架的力学行为
J Thorac Dis. 2017 Aug;9(Suppl 9):S923-S934. doi: 10.21037/jtd.2017.06.30.
8
The Systems Biocompatibility of Coronary Stenting.冠状动脉支架置入术的系统生物相容性
Interv Cardiol Clin. 2016 Jul;5(3):295-306. doi: 10.1016/j.iccl.2016.02.001. Epub 2016 Jun 21.
9
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.对比依维莫司洗脱生物可吸收支架与依维莫司洗脱金属支架治疗冠状动脉狭窄的疗效(ABSORB II):3 年随机、对照、单盲、多中心临床试验。
Lancet. 2016 Nov 19;388(10059):2479-2491. doi: 10.1016/S0140-6736(16)32050-5. Epub 2016 Oct 30.
10
Possible mechanical causes of scaffold thrombosis: insights from case reports with intracoronary imaging.支架内血栓形成的可能机械原因:冠状动脉内影像学病例报告的启示。
EuroIntervention. 2017 Feb 20;12(14):1747-1756. doi: 10.4244/EIJ-D-16-00471.

多模态加载环境预测生物可吸收血管支架的耐久性。

Multimodal Loading Environment Predicts Bioresorbable Vascular Scaffolds' Durability.

机构信息

Institute for Medical Engineering & Science, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Building E25-442, Cambridge, MA, 02139, USA.

Laboratory of Biological Structure Mechanics, Department of Chemistry, Materials and Chemical Engineering 'Giulio Natta', Politecnico di Milano, Milan, Italy.

出版信息

Ann Biomed Eng. 2021 May;49(5):1298-1307. doi: 10.1007/s10439-020-02673-z. Epub 2020 Oct 29.

DOI:10.1007/s10439-020-02673-z
PMID:33123828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8366274/
Abstract

Bioresorbable vascular scaffolds were considered the fourth generation of endovascular implants deemed to revolutionize cardiovascular interventions. Yet, unexpected high risk of scaffold thrombosis and post-procedural myocardial infractions quenched the early enthusiasm and highlighted the gap between benchtop predictions and clinical observations. To better understand scaffold behavior in the mechanical environment of vessels, animal, and benchtop tests with multimodal loading environment were conducted using industrial standard scaffolds. Finite element analysis was also performed to study the relationship among structural failure, scaffold design, and load types. We identified that applying the combination of bending, axial compression, and torsion better reflects incidence observed in-vivo, far more than tranditional single mode loads. Predication of fracture locations is also more accurate when at least bending and axial compression are applied during benchtop tests (>60% fractures at connected peak). These structural failures may be initiated by implantation-induced microstructural damages and worsened by cyclic loads from the beating heart. Ignoring the multi-modal loading environment in benchtop fatigue tests and computational platforms can lead to undetected potential design defects, calling for redefining consensus evaluation strategies for scaffold performance. With the robust evaluation strategy presented herein, which exploits the results of in-vivo, in-vitro and in-silico investigations, we may be able to compare alternative designs of prototypes at the early stages of device development and optimize the performance of endovascular implants according to patients-specific vessel dynamics and lesion configurations in the future.

摘要

生物可吸收血管支架被认为是第四代血管内植入物,有望彻底改变心血管介入治疗。然而,支架血栓形成和术后心肌梗死的高风险超出预期,这使得人们对该技术的早期热情冷却下来,也凸显了实验室预测与临床观察之间的差距。为了更好地了解支架在血管的力学环境中的行为,我们使用工业标准的支架进行了动物和台架测试,并采用多模态加载环境。还进行了有限元分析,以研究结构失效、支架设计和载荷类型之间的关系。我们发现,施加弯曲、轴向压缩和扭转的组合能更好地反映体内观察到的情况,比传统的单一模式负荷更有效。当在台架测试中施加至少弯曲和轴向压缩时(>60%的骨折发生在连接峰值处),对骨折部位的预测也更准确。这些结构失效可能是由植入引起的微结构损伤引发的,并因心脏跳动产生的循环载荷而恶化。在台架疲劳试验和计算平台中忽略多模态加载环境,可能会导致潜在设计缺陷未被发现,因此需要重新定义支架性能的共识评估策略。通过本文提出的稳健评估策略,利用体内、体外和计算机模拟研究的结果,我们或许能够在设备开发的早期阶段比较不同原型设计,并根据患者特定的血管动力学和病变配置来优化血管内植入物的性能。